Profile
- Research in preclinical and GMP-related radiopharmacy, biomedical engineering, instrumentation, dosimetry, and artificial intelligence. Preclinical PET imaging, clinical PET imaging including total-body PET in the context of oncological, neurological and cardiovascular diseases (early diagnosis, differential diagnosis) with the aim to improve molecular imaging techniques. Further, establish the therapeutic spectrum in Nuclear Medicine with the advent of novel radioligand therapies.
- Teaching students in the fields of medicine, biomedical engineering, and radiochemistry. Education of NM technologists.
External Partners
Dept. of Nuclear Medicine, Technical University Munich; Dept. of Nuclear Medicine, Ludwig-Maximilian-University Munich; Fudan University Shanghai, China; Institute of Nuclear Chemistry, Johannes Gutenberg-University Mainz; Kindai University Osaka, Japan; MGH PET Core, Harvard Medical School, USA; Dept. of Molecular Pharmacology, UCLA, USA; School of Medical Technology, Peking University, Beijing, China; Dept. of Nuclear Medicine, Shanghai Jiaotong University, China; UC Davis, USA.
Grants
- Swiss National Science Foundations (grant no. 200021_188914; IZKSW3_188350; 310030_192704; 200021E_216944 / 1)
- BCPM
- Foundation for Clinical and Experimental Tumor Research
- SBFI (grant no. 101073231)
- Novartis Foundation for medical-biological Research (grant no. 22B128)
- Parkinson Schweiz